Detalles de la búsqueda
1.
TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.
J Immunol
; 205(3): 830-841, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591397
2.
Tumor immune microenvironment in head and neck cancers.
Mol Carcinog
; 59(7): 766-774, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32017286
3.
TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.
J Immunol
; 201(11): 3421-3430, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30341187
4.
Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.
Int J Mol Sci
; 21(18)2020 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32916850
5.
Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders.
Front Immunol
; 14: 1100520, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37051229
6.
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.
Front Immunol
; 13: 992630, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36330507
7.
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.
J Exp Clin Cancer Res
; 41(1): 123, 2022 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35366939
8.
MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cells.
Cell Mol Immunol
; 18(3): 723-734, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32427883
9.
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
J Immunother Cancer
; 9(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33414263
10.
Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFß/PD-L1 blockade-treated squamous cell carcinoma.
Commun Biol
; 4(1): 1005, 2021 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433873
11.
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma.
Protein Cell
; 11(7): 472-482, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162275
12.
Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell Lymphomas.
Cancer Immunol Res
; 7(8): 1318-1331, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31235619
13.
Fibroblast growth factor 8 deficiency compromises the functional response of the serotonergic system to stress.
PLoS One
; 9(7): e101420, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24992493
Resultados
1 -
13
de 13
1
Próxima >
>>